Aluminum in Vaccines - Is It Safe?
Aluminum Injection Experimentation
Dr. Christopher Exley on Aluminum Adjuvants in Vaccines
Aluminum: A misdiagnosed Epidemic
Mechanisms in Aluminum Adjuvant Toxicity
Aluminum-hydroxide in vaccines causes serious health problems
Aluminum Phagocytosis in Quadriceps Muscle following Vaccination in Children: Relationship to Macrophagic Myofasciitis
Aluminum - Health Problems
Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration
Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.
Do Aluminum Adjuvants Contribute to the Rising Prevalence of Autism- Journal of Inorganic Biochemistry
- Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?Our results show that: (i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades;and (iii) a significant correlation exists between the amounts of Al administered to preschool children and the current prevalence of ASD in seven Western countries, particularly at 3-4 months of age.
Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration.…A second series of experiments was conducted on mice injected with six doses of aluminum hydroxide. Behavioural analyses in these mice revealed significant impairments in a number of motor functions as well as diminished spatial memory capacity.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819810/...
"Aluminium is widely used as an adjuvant in human vaccines, and children can often receive up to 3.75 mg of parenteral aluminium during the first six months of life. We show that intraperitoneal injection of aluminium adsorbed vaccines into mice causes a transient rise in brain tissue aluminium levels peaking around the second and third day after injection. This rise is not seen in the saline control group of animals or with vaccine not containing aluminium. It is likely that aluminium is transported to the brain by the iron-binding protein transferrin and enters the brain via specific transferrin receptors."http://www.ncbi.nlm.nih.gov/m/pubmed/1608913/
Aluminum Vaccine Adjuvants: Are they Safe?
Experimental research, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences.http://www.ncbi.nlm.nih.gov/pubmed/21568886
Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations"Immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune function. Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In some developed countries, by the time children are 4 to 6 years old, they will have received a total of 126 antigenic compounds along with high amounts of aluminum (Al) adjuvants through routine vaccinations. According to the US Food and Drug Administration, safety assessments for vaccines have often not included appropriate toxicity studies because vaccines have not been viewed as inherently toxic. Taken together, these observations raise plausible concerns about the overall safety of current childhood vaccination programs. When assessing adjuvant toxicity in children, several key points ought to be considered: (i) infants and children should not be viewed as "small adults" with regard to toxicological risk as their unique physiology makes them much more vulnerable to toxic insults; (ii) in adult humans Al vaccine adjuvants have been linked to a variety of serious autoimmune and inflammatory conditions (i.e., "ASIA"), yet children are regularly exposed to much higher amounts of Al from vaccines than adults; (iii) it is often assumed that peripheral immune responses do not affect brain function. However, it is now clearly established that there is a bidirectional neuro-immune cross-talk that plays crucial roles in immunoregulation as well as brain function. In turn, perturbations of the neuro-immune axis have been demonstrated in many autoimmune diseases encompassed in "ASIA" and are thought to be driven by a hyperactive immune response; and (iv) the same components of the neuro-immune axis that play key roles in brain development and immune function are heavily targeted by Aluminum adjuvants.In summary, research evidence shows that increasing concerns about current vaccination practices may indeed be warranted. Because children may be most at risk of vaccine-induced complications, a rigorous evaluation of the vaccine-related adverse health impacts in the pediatric population is urgently needed."http://www.ncbi.nlm.nih.gov/pubmed/22235057•Do aluminum vaccine adjuvants contribute to ... [J Inorg Biochem. 2011] - PubMed - NCBI www.ncbi.nlm.nih.gov